Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segmen...
Beyond Air (XAIR) Receives a Hold from BTIG
Beyond Air trading halted, news pending
Beyond Air Implements Reverse Stock Split to Maintain Listing
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Beyond Air | 8-K: FY2026 Revenue Misses Estimate at USD 7.679 M
Beyond Air, Inc. FY 2026: Revenue $7.7M, EPS $(4.01) — 10-K Summary